Period Ending | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jul 1, 2012 |
---|
Total Revenue
|
17,505,000
|
17,558,000
|
17,052,000
|
16,475,000
| Cost of Revenue | 5,554,000 | 6,003,000 | 5,597,000 | 5,143,000 | |
Gross Profit
|
11,951,000
|
11,555,000
|
11,455,000
|
11,332,000
| |
|
Operating Expenses |
|
Research Development | 1,784,000 | 2,331,000 | 1,923,000 | 1,766,000 |
|
Selling General and Administrative | 5,223,000 | 5,661,000 | 5,228,000 | 4,965,000 |
|
Non Recurring | 64,000 | 55,000 | 679,000 | 429,000 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
4,880,000
|
3,508,000
|
3,625,000
|
4,172,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (494,000) | (301,000) | 105,000 | (1,994,000) |
|
Earnings Before Interest And Taxes | 4,386,000 | 3,207,000 | 3,730,000 | 2,178,000 |
|
Interest Expense | 125,000 | 107,000 | 135,000 | 143,000 |
|
Income Before Tax | 4,261,000 | 3,100,000 | 3,595,000 | 2,035,000 |
|
Income Tax Expense | 764,000 | 533,000 | 966,000 | 627,000 |
|
Minority Interest |
-
|
-
| 339,000 |
-
|
|
|
|
Net Income From Continuing Ops | 3,497,000 | 2,567,000 | 2,968,000 | 1,408,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
3,497,000
|
2,567,000
|
2,968,000
|
1,408,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
3,497,000
|
2,567,000
|
2,968,000
|
1,408,000
|
|